This company listing is no longer active
Atreca Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
John Orwin
Chief executive officer
US$927.0k
Total compensation
| CEO salary percentage | 64.83% |
| CEO tenure | 6yrs |
| CEO ownership | 0.2% |
| Management average tenure | 4.8yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$98m |
| Jun 30 2023 | n/a | n/a | -US$85m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$927k | US$601k | -US$97m |
| Sep 30 2022 | n/a | n/a | -US$105m |
| Jun 30 2022 | n/a | n/a | -US$110m |
| Mar 31 2022 | n/a | n/a | -US$108m |
| Dec 31 2021 | US$4m | US$583k | -US$109m |
| Sep 30 2021 | n/a | n/a | -US$103m |
| Jun 30 2021 | n/a | n/a | -US$98m |
| Mar 31 2021 | n/a | n/a | -US$92m |
| Dec 31 2020 | US$5m | US$567k | -US$86m |
| Sep 30 2020 | n/a | n/a | -US$83m |
| Jun 30 2020 | n/a | n/a | -US$76m |
| Mar 31 2020 | n/a | n/a | -US$74m |
| Dec 31 2019 | US$845k | US$507k | -US$67m |
| Sep 30 2019 | n/a | n/a | -US$59m |
| Jun 30 2019 | n/a | n/a | -US$53m |
| Mar 31 2019 | n/a | n/a | -US$44m |
| Dec 31 2018 | US$5m | US$319k | -US$38m |
Compensation vs Market: John's total compensation ($USD927.03K) is above average for companies of similar size in the German market ($USD398.66K).
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
CEO
John Orwin (58 yo)
Mr. John A. Orwin, M.B.A. serves as Chairman of the Board for Nested Therapeutics since February 2024. He serves as Chairman of the Board of AnaptysBio, Inc. since September 15, 2023. He has been President...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6yrs | US$927.03k | 0.20% € 5.5k | |
| Founder & Director | no data | US$665.50k | 0.74% € 20.9k | |
| Principal Accounting Officer | less than a year | no data | no data | |
| General Counsel & Corporate Secretary | 4.8yrs | no data | 0.073% € 2.1k | |
| Vice President of Finance | no data | no data | 0.067% € 1.9k |
Experienced Management: 0C1's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6yrs | US$927.03k | 0.20% € 5.5k | |
| Founder & Director | 14.3yrs | US$665.50k | 0.74% € 20.9k | |
| Independent Chairman of the Board | 10.3yrs | US$97.77k | 0.13% € 3.5k | |
| Chairman of External Scientific Advisory Board & Technical Advisor | 4.7yrs | US$150.00k | no data | |
| Independent Director | 9.5yrs | US$71.77k | 0.25% € 7.0k | |
| Independent Director | 3.9yrs | US$64.27k | 0% € 0 | |
| Director | 13.3yrs | US$312.77k | 0.93% € 26.3k | |
| Independent Director | 7.9yrs | US$70.77k | 0% € 0 | |
| Board Observer | no data | no data | no data | |
| Board Observer | no data | no data | no data | |
| Independent Director | 4.7yrs | US$62.77k | 0% € 0 | |
| Independent Director | 2.8yrs | US$57.77k | 0% € 0 |
Experienced Board: 0C1's board of directors are considered experienced (7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/17 23:11 |
| End of Day Share Price | 2024/01/19 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Atreca, Inc. is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Ulz | Baird |
| Kumaraguru Raja | Brookline Capital Markets |
| John Newman | Canaccord Genuity |